2017 AACR Hematologic Malignancies Conference - CG’806, a First‐in‐Class FLT3/BTK Inhibitor, Exerts Superior Potency Against AML Cells Harboring FLT3‐ITD, TKD, and Gatekeeper Mutant or Wild‐Type FLT3 May 7, 2017
2017 AACR Hematologic Malignancies Conference - CG’806, a First-in-Class FLT3/BTK Inhibitor, Exhibits Potent Activity Against AML May 7, 2017
2016 ASH Poster - Inhibition of c-Myc by APTO-253 as an Innovative Therapeutic Approach to Induce Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia Dec 3, 2016
